Trial intelligence / Profile preview

Phase 2 study of INCB054828 in previously treated advanced cholangiocarcinoma with FGFR alterations

2016-002422-36Phase 2Completed

Sponsor

Incyte

Start

Feb 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1